SPAC business combination shareholder approval
Company: Core Scientific
The claim, verbatim
XPDI stockholders approved the business combination transactions at special stockholder meeting held on January 19, 2022
Source (primary)
Core Scientific 10-K filed 2023-04-04 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗
Quote: “XPDI's stockholders approved the transactions contemplated by the Business Combination at a special meeting of stockholders held on January 19, 2022”
How we checked this
Checked on September 21, 2026. The cited source supports every part of this claim.
The document states the stockholders approved the transactions at a special meeting on January 19, 2022.
Confirmed in the source:
- XPDI stockholders approved the Business Combination at a special meeting held January 19, 2022
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1839341/000162828023010454/core-20221231.htm) in full (860,799 characters, retrieved September 13, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific 10-K filed 2023-04-04
Quote: “XPDI's stockholders approved the transactions contemplated by the Business Combination at a special meeting of stockholders held on January 19, 2022”
